ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA CMML PANEL Test
Test Name: ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA CMML PANEL Test
Test Components: ABL1, ASXL1, BCOR, CBL, CSF3R, CALR, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NF1, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, SH2B3, TET2, TP53, U2AF1, ZRSF2 FUSION GENE – ABL1, ETV6, JAK2, KMT2A, RUNX1
Price: 8190.0 AED
Sample Condition: 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Form is mandatory.
Report Delivery: Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Method: NGS
Test type: Leukemia
Doctor: Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.
Test Details
The Oncomine Chronic Myelomonocytic Leukemia (CMML) Panel Test is a diagnostic tool used to detect genetic mutations in patients with CMML, a type of blood cancer that affects the bone marrow. This panel test analyzes a set of genes that are commonly mutated in CMML, including ASXL1, TET2, SRSF2, and DNMT3A, among others. By identifying these mutations, the test can help doctors determine the most appropriate treatment options for patients with CMML. The Oncomine CMML Panel Test is performed using a small blood sample and is typically ordered by a hematologist or oncologist.
Test Name | ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA CMML PANEL Test |
---|---|
Components | ABL1, ASXL1, BCOR, CBL, CSF3R, CALR, DNMT3A, ETV6, EZH2, FLT3, GATA2, HRAS, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NF1, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, SH2B3, TET2, TP53, U2AF1, ZRSF2 FUSION GENE – ABL1, ETV6,JAK2, KMT2A,RUNX1, |
Price | 8190.0 AED |
Sample Condition | 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample by 1st / 16th of every month; Report 15th / 30th of Same month |
Method | NGS |
Test type | Leukemia |
Doctor | Hematologist, Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details | The Oncomine Chronic Myelomonocytic Leukemia (CMML) Panel Test is a diagnostic tool used to detect genetic mutations in patients with CMML, a type of blood cancer that affects the bone marrow. This panel test analyzes a set of genes that are commonly mutated in CMML, including ASXL1, TET2, SRSF2, and DNMT3A, among others. By identifying these mutations, the test can help doctors determine the most appropriate treatment options for patients with CMML. The Oncomine CMML Panel Test is performed using a small blood sample and is typically ordered by a hematologist or oncologist. |